Epidemiology of Non- Invasive Mechanical Ventilation in Argentina: a Multicenter Observational Study

Launched by ARGENTINIAN INTENSIVE CARE SOCIETY · Feb 14, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the use of non-invasive mechanical ventilation (NIMV) in hospitals across Argentina. NIMV is a method that helps patients with severe breathing problems without the need for a breathing tube. The goal of the study is to understand how well NIMV works, its effects on patients' survival in intensive care units (ICUs), and how access to this treatment varies in different regions of the country. By gathering this information, researchers hope to improve healthcare decisions and policies regarding respiratory care in Argentina.

To participate in the trial, patients must be over 18 years old and require NIMV in the ICU due to acute breathing issues. Participants will be monitored throughout their treatment until they either leave the hospital or experience a serious outcome. The study will collect data for seven months and will ensure patient confidentiality and safety. This research is important because it aims to provide valuable insights that could enhance the quality of care for patients needing respiratory support across the country.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients over 18 years of age.
• • Requirement of NIMV in ICU due to acute respiratory failure (hypoxemic or hypercapnic or mixed) or as part of the process of weaning from mechanical ventilation.
• • Patients who receive NIMV as a palliative or as part of end-of-life care.
• • Patients as a routine treatment who require an increase in the time of use, or the level of support, or both due to increased demand.
• • Informed consent signed by the patient or his/her legal representative in the event that the patient is incapacitated.
• Exclusion Criteria:
• • Patients admitted to the ICU with NIV as standard treatment for chronic lung disease, neuromuscular disease, obstructive sleep apnea-hypopnea syndrome, or obesity hypoventilation syndrome without additional respiratory compromise.